Last edition
News about "Zimmer Biomet to Acquire Monogram Technologies, Ad"
The acquisition is set to expand Zimmer Biomet’s ROSA Robotics platform with Monogram’s advanced AI-powered, CT-based semi-autonomous total knee arthroplasty (TKA) system—cleared by the FDA in March 2025. A fully autonomous version is also in development, with the potential to revolutionise surgical precision, safety, and outcomes.
Zimmer Biomet To Acquire Monogram Technologies, Ad | 16/07/2025 | By Darshana | 252
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members